The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Pharmacogenetics and drug development: the path to safer and more effective drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L., & Nickerson, D. A. (2004) · The American Journal of Human Genetics · doi:10.1086/381000 · Cited by 1,589
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Candidate-gene approaches for studying complex genetic traits: practical considerations
Tabor, H. K., Risch, N. J., & Myers, R. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg796 · Cited by 1,076
Clinical application of pharmacogenetics
Spear, B. B., Heath-Chiozzi, M., & Huff, J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01986-4 · Cited by 646
Drazen, J. M., Yandava, C. N., Dubé, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 560
A first-generation linkage disequilibrium map of human chromosome 22
Dawson, E., Abecasis, G. R., Bumpstead, S., Chen, Y., Hunt, S., Beare, D. M., Pabial, J., Dibling, T., Tinsley, E., Kirby, S., et al. (2002) · Nature · doi:10.1038/nature00864 · Cited by 402
Linkage disequilibrium and the mapping of complex human traits
Weiss, K. M., & Clark, A. G. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02550-1 · Cited by 398
Lindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 332
Dos Santos, C., Essioux, L., Teinturier, C., Tauber, M., Goffin, V., & Bougnères, P. (2004) · Nature Genetics · doi:10.1038/ng1379 · Cited by 325
Tantisira, K. G., Lake, S., Silverman, E. S., Palmer, L. J., Lazarus, R., Silverman, E. K., Liggett, S. B., Gelfand, E. W., Rosenwasser, L. J., Richter, B., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh149 · Cited by 322
Goldstein, D. B., Tate, S. K., & Sisodiya, S. M. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1229 · Cited by 312
Horrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
Clinical Research<SUBTITLE>Perceptions, Reality, and Proposed Solutions</SUBTITLE>
Nathan, D. G. (1998) · JAMA · doi:10.1001/jama.280.16.1427 · Cited by 218
(1998) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-1998-159 · Cited by 191
The SNP Consortium website: past, present and future
Thorisson, G. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg052 · Cited by 187
Genome-based pharmacogenetics and the pharmaceutical industry
Roses, A. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd840 · Cited by 168
Self-citationGoldstein, D. B., Ahmadi, K. R., Weale, M. E., & Wood, N. W. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.006 · Cited by 162
A 4-Mb High-Density Single Nucleotide Polymorphism-Based Map around Human APOE
Lai, E., Riley, J., Purvis, I., & Roses, A. (1998) · Genomics · doi:10.1006/geno.1998.5581 · Cited by 161
Self-citationMcCarthy, L. C., Hosford, D. A., Riley, J., Bird, M. I., White, N. J., Hewett, D. R., Peroutka, S. J., Griffiths, L. R., Boyd, P. R., Lea, R. A., et al. (2001) · Genomics · doi:10.1006/geno.2001.6647 · Cited by 145
Self-citationA single-nucleotide polymorphism tagging set for human drug metabolism and transport
Ahmadi, K. R., Weale, M. E., Xue, Z., Soranzo, N., Yarnall, D. P., Briley, J. D., Maruyama, Y., Kobayashi, M., Wood, N. W., Spurr, N. K., et al. (2004) · Nature Genetics · doi:10.1038/ng1488 · Cited by 142
Self-citationTarget selection for structural genomics.
Brenner, S. E. (2000) · Nature Structural Biology · doi:10.1038/80747 · Cited by 134
Implications of the Human Genome for Understanding Human Biology and Medicine
Subramanian, G., Adams, M. D., Venter, J. C., & Broder, S. (2001) · JAMA · doi:10.1001/jama.286.18.2296 · Cited by 134
Hewett, D. R., Samuelsson, L., Polding, J., Enlund, F., Smart, D. H., Cantone, K. L., See, C. G., Chadha, S., Inerot, A., Enerbäck, C., et al. (2002) · Genomics · doi:10.1006/geno.2002.6720 · Cited by 109
Self-citationFulfilling the promise: drug discovery in the post-genomic era
Chanda, S. K., & Caldwell, J. S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02595-3 · Cited by 104
The Impact of Genomics on Drug Discovery
Debouck, C., & Metcalf, B. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.193 · Cited by 96
Pharmacophylogenomics: genes, evolution and drug targets
Searls, D. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1152 · Cited by 91
Linkage of Essential Hypertension to Chromosome 18q
Kristjánsson, K., Manolescu, A. R., Kristinsson, A., Hardarson, T., Knudsen, H., Ingason, S., Þorleifsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000018580.24644.18 · Cited by 90
Duyk, G. M. (2003) · Science · doi:10.1126/science.1090521 · Cited by 89
Sesti, G., Marini, M. A., Cardellini, M., Sciacqua, A., Frontoni, S., Andreozzi, F., Irace, C., Lauro, D., Gnasso, A., Federici, M., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1394 · Cited by 82
Welsh‐Bohmer, K. A., Gearing, M., Saunders, A. M., Roses, A. D., & Mirra, S. (1997) · Annals of Neurology · doi:10.1002/ana.410420308 · Cited by 67
Self-citationClinical Experience with Trastuzumab (Herceptin)
Vogel, C. L., & Franco, S. X. (2003) · The Breast Journal · doi:10.1046/j.1524-4741.2003.09602.x · Cited by 65
Techniques patents for SNP genotyping
Twyman, R. M., & Primrose, S. B. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.1.67.22582 · Cited by 56
Macedo, A., Farr�, M., & Baños, J.-E. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0612-4 · Cited by 50
Race, Distributive Justice and the Promise of Pharmacogenomics: Ethical Considerations
Lee, S. S. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303060-00005 · Cited by 45
Medical applications of haplotype-based SNP maps: learning to walk before we run
Lai, E., Bowman, C., Bansal, A. T., Hughes, A. R., Mosteller, M., & Roses, A. D. (2002) · Nature Genetics · doi:10.1038/ng1102-353 · Cited by 35
Self-citationImpact of placebo assignment in clinical trials of Parkinson's disease
Goetz, C. G., Janko, K., Blasucci, L. M., & Jaglin, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10504 · Cited by 34
Genetics: an explosion of knowledge is transforming clinical practice.
Collins, F. S. (1999) · PubMed · Cited by 33
Identification of a pharmacogenetic effect by linkage disequilibrium mapping
Xu, C., Lewis, K. F., Yeo, A. J. M., McCarthy, L. C., Maguire, M., Anwar, Z., Danoff, T. M., Roses, A. D., & Purvis, I. J. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500268 · Cited by 20
Self-citationEnabling high-throughput discovery.
Vaschetto, M., Weissbrod, T., Bodle, D., & Güner, O. F. (2003) · PubMed · Cited by 13
2025: The Practice of Neurology
Roses, A. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1766 · Cited by 8
Self-citation
Cited by
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Arranz, M. J., & de Leon, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002009 · Cited by 351
Daly, A. K., Aithal, G. P., Leathart, J. B. S., Swainsbury, R. A., Dang, T. S., & Day, C. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.023 · Cited by 348
de Leon, J., Armstrong, S. C., & Cozza, K. L. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.1.75 · Cited by 300
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy Issues
Hogarth, S., Javitt, G., & Melzer, D. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164319 · Cited by 268
Metadata
- Authors
- Roses, A. D.
- Venue
- Nature Reviews Genetics
- Published
- 2004-09
- Volume
- 5
- Issue
- 9
- Pages
- 645-656
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2031079527
- Cited by
- 268
- References
- 45
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.